Lung cancer risk in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County

被引：31

作者：

London, SJ

SullivanKlose, T

Daly, AK

Idle, JR

机构：

[1] NIEHS,LAB PHARMACOL & CHEM,RES TRIANGLE PK,NC 27709

[2] N CAROLINA STATE UNIV,DEPT TOXICOL,RALEIGH,NC 27695

[3] MED SCH NEWCASTLE UPON TYNE,DEPT PHARMACOL SCI,NEWCASTLE TYNE NE2 4HH,TYNE & WEAR,ENGLAND

[4] MEDISINSK TEKNISK SENTER,INST CANC RES & MOL BIOL,N-7005 TRONDHEIM,NORWAY

来源：

PHARMACOGENETICS | 1997年 / 7卷 / 05期

关键词：

cytochrome P4502C9; cytochrome P4502C; CYP2C; susceptibility; epidemiology;

D O I：

10.1097/00008571-199710000-00010

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：401 / 404

页数：4

共 9 条

[1] OXIDATION OF BENZO[A]PYRENE BY RECOMBINANT HUMAN CYTOCHROME-P450 ENZYMES [J].

BAUER, E ;

GUO, ZY ;

UENG, YF ;

BELL, LC ;

ZELDIN, D ;

GUENGERICH, FP .

CHEMICAL RESEARCH IN TOXICOLOGY, 1995, 8 (01) :136-142

[2] Allelic and functional variability of cytochrome P4502C9 [J].

Bhasker, CR ;

Miners, JO ;

Coulter, S ;

Birkett, DJ .

PHARMACOGENETICS, 1997, 7 (01) :51-58

[3]

DEGAWA M, 1994, CANCER RES, V54, P4915

[4] Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy [J].

Furuya, H ;

FernandezSalguero, P ;

Gregory, W ;

Taber, H ;

Steward, A ;

Gonzalez, FJ ;

Idle, JR .

PHARMACOGENETICS, 1995, 5 (06) :389-392

[5] Lung cancer risk in relation to the CYP2C9*1/CYP2C9*2 genetic polymorphism among African-Americans and Caucasians in Los Angeles County, California [J].

London, SJ ;

Daly, AK ;

Leathart, JBS ;

Navidi, WC ;

Idle, JR .

PHARMACOGENETICS, 1996, 6 (06) :527-533

[6] POLYMORPHISM OF GLUTATHIONE-S-TRANSFERASE M1 AND LUNG-CANCER RISK AMONG AFRICAN-AMERICANS AND CAUCASIANS IN LOS-ANGELES-COUNTY, CALIFORNIA [J].

LONDON, SJ ;

DALY, AK ;

COOPER, J ;

NAVIDI, WC ;

CARPENTER, CL ;

IDLE, JR .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (16) :1246-1253

[7] IMPAIRED (S)-WARFARIN METABOLISM CATALYZED BY THE R144C ALLELIC VARIANT OF CYP2C9 [J].

RETTIE, AE ;

WIENKERS, LC ;

GONZALEZ, FJ ;

TRAGER, WF ;

KORZEKWA, KR .

PHARMACOGENETICS, 1994, 4 (01) :39-42

[8] THE ROLE OF 12-CDNA-EXPRESSED HUMAN, RODENT, AND RABBIT CYTOCHROMES-P450 IN THE METABOLISM OF BENZO[A]PYRENE AND BENZO[A]PYRENE TRANS-7,8-DIHYDRODIOL [J].

SHOU, MG ;

KORZEKWA, KR ;

CRESPI, CL ;

GONZALEZ, FJ ;

GELBOIN, HV .

MOLECULAR CARCINOGENESIS, 1994, 10 (03) :159-168

[9] The role of the CYP2C9-Leu(359) allelic variant in the tolbutamide polymorphism [J].

SullivanKlose, TH ;

Ghanayem, BI ;

Bell, DA ;

Zhang, ZY ;

Kaminsky, LS ;

Shenfield, GM ;

Miners, JO ;

Birkett, DJ ;

Goldstein, JA .

PHARMACOGENETICS, 1996, 6 (04) :341-349

← 1 →